To include your compound in the COVID-19 Resource Center, submit it here.
Top-line data from the double-blind, U.S. Phase IV Study SPD489-405 in 459 ADHD patients aged 13-17 years showed that once-daily
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury